Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Intensified Cyclophophamide, Carboplatin and Thiotepa|DRUG: dose dense adriamycine and cyclophosphamide
Sponsor: The Netherlands Cancer Institute